female

(redirected from Female sexual arousal disorder)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to Female sexual arousal disorder: Hypoactive sexual desire disorder, Sexual aversion disorder

female

noun female being, female gender, female sex, gender, girl, her, herself, lady, miss, mrs., ms., she, woman
Associated concepts: women's rights
Foreign phrases: Feme, Femme.A woman. Feme covert. Amarried woman. Feme sole. A single woman.
References in periodicals archive ?
The patient with female sexual arousal disorder seeks help because she's not having sexy thoughts.
The multicenter study, which was conducted in Canada, Europe, and Australia, involved premenopausal and postmenopausal women who were taking hormone replacement therapy and had been diagnosed with female sexual arousal disorder, one of several categories that fall under the broad heading of sexual dysfunction, Dr.
NexMed's pipeline includes its innovative topical onychomycosis treatment, which is licensed to Novartis for global development, a late stage alprostadil treatment for erectile dysfunction, a Phase 2 treatment for female sexual arousal disorder, and an early stage treatment for psoriasis.
announced today positive results from an at-home Phase 2 trial evaluating bremelanotide for the treatment of female sexual arousal disorder (FSAD).
NexMed's pipeline also includes its late stage alprostadil treatment for erectile dysfunction, a Phase 2 treatment for female sexual arousal disorder, and an early stage treatment for psoriasis.
The purpose of Part 1 of this 2-Part Phase IIa pilot study was to evaluate the effect of bremelanotide, a first-in-class melanocortin agonist, in 18 premenopausal women, ages 22 to 44 years old, diagnosed with female sexual arousal disorder (FSAD).
Nasdaq: NEXM), a developer of innovative products based on the NexACT([R]) drug delivery technology, today confirmed that previously unpublished clinical data on Femprox, the Company's topical treatment for female sexual arousal disorder, was published in the August 2008 issue of The Journal of Sexual Medicine.
John Buster, Professor, Baylor College of Medicine, and principal investigator for Evamist(TM) trial -- ALISTA(TM) -- Presentation of data from Phase 2B program for the treatment of Female Sexual Arousal Disorder (FSAD) by Dr.